Richards, Merrill & Peterson’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.59M Sell
6,014
-85
-1% -$22.4K 0.49% 46
2026
Q2
$1.55M Buy
6,099
+257
+4% +$59.9K 0.49% 51
2026
Q1
$1.43M Buy
5,842
+68
+1% +$15.8K 0.52% 51
2025
Q4
$1.19M Buy
5,774
+936
+19% +$185K 0.46% 59
2025
Q3
$897K Sell
4,838
-8
-0.2% -$1.37K 0.39% 72
2025
Q2
$740K Buy
4,846
+328
+7% +$50.4K 0.35% 76
2025
Q1
$749K Buy
4,518
+2
+0% +$313 0.39% 68
2024
Q4
$653K Buy
+4,516
New +$700K 0.34% 75

Other funds holding JNJ

Richards, Merrill & Peterson's JNJ Position: Q3 2026 in Review

Richards, Merrill & Peterson reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q3 2026, selling an estimated $22.4K and leaving 6,014 shares worth $1.59M. The position accounts for 0.49% of the portfolio, ranked #46.

Richards, Merrill & Peterson first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,739 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Richards, Merrill & Peterson held 6,014 shares of Johnson & Johnson worth $1.59M as of Q3 2026.
  • Richards, Merrill & Peterson sold 85 Johnson & Johnson shares in Q3 2026, an estimated $22.4K.
  • Johnson & Johnson made up 0.49% of Richards, Merrill & Peterson's portfolio in Q3 2026, its #46 holding.
  • Richards, Merrill & Peterson first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,739 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q3 2026, filed 19 Oct 2026.